Navigation Links
Blood Thinning Medication Could Prevent Strokes

Anticoagulation therapy is used to treat deep vein thrombosis, which is a blood clot in veins of the legs, pelvis or arms. Researchers say several new studies show the medication ximelagatran (Exanta), could simplify anticoagulation therapy.//

In the first study, researchers studied DVT( Deep vein thrombosis) patients and compared the effectiveness and safety of ximelagatran compared to standard treatment with the anticoagulants enoxaparin (Lovenox) and warfarin (Coumadin). Current therapy for patients with acute venous thromboembolism consists of about a week of the anticoagulant heparin (Calciparine or Liquaemin) overlapped with and followed by long-term, oral anticoagulation therapy such as warfarin. Warfarin is given orally but is associated with unpredictable responses, and continued monitoring and adjustments are therefore necessary. Researchers found ximelagatran was as effective as enoxaparin/warfarin without the need for coagulation monitoring or dose adjustment.

In another study, researchers studied the effectiveness of ximelagatran compared to warfarin for prevention of strokes in patients with atrial fibrillation.It was found that the primary event rate for strokes associated with ximelagatran was 1.6 percent per year and with warfarin was 1.2 percent per year and there was no major difference between treatment groups in rates of major bleeding, but total bleeding was lower with ximelagatran.
'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... A four alarm fire ... site and threatened numerous homes and businesses nearby, causing some 700 individuals to ... Los Angeles Area consulting firm Fire Protection Group, Inc. notes that the report ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin care product, ... of the leading causes of long term skin conditions, including cancer. In ...
(Date:7/24/2017)... ... July 24, 2017 , ... The 2017 ... MD. This year's theme focuses on the new ISO/IEC 17025 standards. This marks ... integrity in testing and calibration will be changed. , As an exhibitor, ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... received the prestigious StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in ... 11th annual StorErotica Awards to be consumer voted. The Magic Wand Rechargeable won ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... Medicine Clinical Vitiligo Hospital" was set up, and the awarding ceremony was held ... Chinese medicine, the head of the army's health system, and national Chinese medicine ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)...  Centurion Medical Products, a leader in medical product innovation and ... removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of a ... pain while preventing unneeded emergency department admission due to severe fecal ...
(Date:7/11/2017)... July 11, 2017 Zymo Research Corp., also known as ,The ... quantify biological aging in a precise manner using the myDNAge ™ ... , a professor of human genetics and biostatistics at the David ... Public Health , Zymo Research,s proprietary DNAge ™ technology is used ... ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
Breaking Medicine Technology: